Natriuresis following central and peripheral administration of agmatine in the rat

Pharmacology

Volumn 53, Issue 3, 1996, Pages 160-169

  Penner, S Brian ^a   Smyth, Donald D ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Agmatine; Clonidine displacing; Imidazoline receptor; Substance

Indexed keywords

AGMATINE; CREATININE; IMIDAZOLINE RECEPTOR; PENTOBARBITAL;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE CLEARANCE; DIURESIS; DOSE RESPONSE; DRUG EFFECT; HEART RATE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NATRIURESIS; NONHUMAN; OSMOTIC DIURESIS; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; URINE FLOW RATE;

AGMATINE; ANIMALS; BLOOD PRESSURE; CREATININE; HEART RATE; IMIDAZOLES; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; KIDNEY; MALE; NATRIURESIS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DRUG; URODYNAMICS;

EID: 0029908660     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139427     Document Type: Article

References (28)

1. Pcnncr SB, Smyth DD: Chronic prazosin attenuates the natriuretic response to a modest saline load in rats, Br J Pharmacol 1988:93:446-452.
2. Blandford DE, Smyth DD: Role of vasopressin in response to intrarcnal infusions of β-adrenoceptor agonists, J Pharmacol Exp Thcr 1990: 255:264-270.
3. Smyth DD, Li P, Blandford DE, Penner SB: Opposite rank order of potency for clonidine, 2.6-dimethyl-clonidinc and UK 14.304 on water and solute excretion in the rat, Two sites and/or receptors? J Pharmacol Exp Thcr 1992:261:1080-1086.
4. Bousquet P, Feldman J, Schwartz J: Central cardiovascular effects of the alpha-adrenergic drugs: Differences between catecholamines and imidazolines, J Pharmacol Exp Ther 1984:230:232-236.
5. Ernsbcrger P, Mecly MP, Mann JJ, Reis DJ: Clonidine binds to imidazoline binding sites as well as coadrenoceptors in the ventrolateral medulla, Eur J Pharmacol 1987; 134:1-13.
6. Ernsbergcr P, Giuliano R, Willette RN, Granata AR, Reis DJ: Hypotensive action of clonidine analogues correlates with binding affinity at imidazole and not alpha-2-adrcncrgic receptors in the rostral ventrolateral medulla, J Hypertens 1988:6(suppl 4):S554-S557
7. 3H]idazoxan and some other alpha-2-adrenergic drugs also bind with a high affinity to a non-adrencrgic site, Mol Pharmacol 1989:35:324-330.
8. Michel MC, Regan JW, Gerhardt MA, Neubig RR, Insel PA, Motulsky HJ: Nonadrenergie [’Hjidazox-an binding sites are physically distinct from alpha-2-adrcnergic receptors, Mol Pharmacol 1990:37:65-68.
9. Emsberger P, Westbrooks KL, Christen MO, Schafer SG: A second generation of centrally acting antihypertensive agents act on putative li-imidazolinc receptors, J Cardio-vasc Pharmacol 1992;20:S 1-S10.
10. Reis DJ, Regunathan S, Wang H, Feinstcin DL, Mecly MP: Imidazoline receptors in the nervous system, Fundam Clin Pharmacol 1992: 6(suppl 1):23s-29s.
11. Hamilton CA: The role of imidazoline receptors in blood pressure regulation, Pharmacol Ther 1992:54: 231-248.
12. Tibirica E, Feldman J, Mermct C, Gonon F, Bousquet P: An imidazoline-specific mechanism for the hypotensive effect of clonidine: A study with yohimbine and idazoxan, J Pharmacol Exp Ther 1991:256: 606-613.
13. Ernsbcrger P, Giuliano R, Willette RN, Reis DJ: Role of imidazoline receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla, J Pharmacol Exp Ther 1990:253:408-418.
14. Ernsbcrger P, Damon HD, Graff LM, Schafer SG, Christen MO: Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I i-imidazoline sites, J Pharmacol Exp Ther 1993:264:172-182.
15. Allan DR, Penner SB, Smyth DD: Renal imidazoline preferring sites and solute excretion in the rat, Br J Pharmacol 1993;108:870-875.
16. Li P, Penner SB, Smyth DD: Attenuated response to moxonidine and rilmenidine in one kidney-one clip hypertensive rats, Br J Pharmacol 1994;112:200-206.
17. Penner SB, Smyth DD: Sodium excretion following central administration of an 11 imidazoline receptor agonist, moxonidine, Br J Pharmacol 1994;112:1089-1094.
18. Penner SB, Smyth DD: Central and renal fi imidazoline preferring receptors: Two unique sites mediating natriuresis in the rat, Cardiovasc Drugs Ther 1994;8:43-48.
19. Atlas D, Burnstein Y: Isolation of an partial purification of a clonidine displacing endogenous brain substance, Eur J Biochem 1984:144: 287-293.
20. Meeley MP, Ernsbergcr PR, Granata AR, Reis DJ: An endogenous clonidine displacing substance from bovine brain: Receptor binding and hypotensive actions in the ventrolateral medulla, Life Sci 1986:38: 1119-1126.
21. Li G, Regunthan S, Barrow CJ, Eshraghi J, Cooper R, Reis D: Ag-matine, an endogenous clonidine-displacing substance in the brain, Science 1994;263:966-969.
22. Penner SB, Smyth DD, Glavin GB: Decreased gastric acid output following neuropeptide Y administration into the lateral cerebral ventricle of conscious rats, Ann NY Acad Sci 1990:597:43-50.
23. a and u^-adreno-ceptor agonists in anaesthetized cats, BrJ Pharmacol 1989:98:1157-1164.
24. Li P, Smyth DD: Suppressed renal response to 2,6-dimethylclonidine but not clonidine in one kidnev-one clip hypertensive rats, J Pharmacol Exp Ther 1993;267:1395-1400.
25. Blandford DE, Smyth DD: Dose-selective dissociation of water and solute excretion after renal alpha-2-adrenoceptor stimulation, J Pharmacol Exp Ther 1988:247:1181-1186.
26. Peterson OW, Lortie M, Blantz RC: Agmatine effects on and glomerular hemodynamics (abstract), J Am Soc Nephrol 1994;5:609.
27. Glavin GB, Smyth DD: Effects of the selective fi imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats, BrJ Pharmacol 1995:114:751-754.
28. Glavin GB, Carlisle MA, Smyth DD: Agmatine, an endogenous imidazoline receptor agonist, increases gastric secretion and worsens experimental gastric mucosal injury in rats, J Pharmacol Exp Ther 1995;274:741-744.